DK1095278T3 - Differentialdiagnose af neurodegeneration - Google Patents
Differentialdiagnose af neurodegenerationInfo
- Publication number
- DK1095278T3 DK1095278T3 DK99934543T DK99934543T DK1095278T3 DK 1095278 T3 DK1095278 T3 DK 1095278T3 DK 99934543 T DK99934543 T DK 99934543T DK 99934543 T DK99934543 T DK 99934543T DK 1095278 T3 DK1095278 T3 DK 1095278T3
- Authority
- DK
- Denmark
- Prior art keywords
- neurodegeneration
- differential diagnosis
- methods
- quantification
- relates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Eye Examination Apparatus (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98870148 | 1998-07-03 | ||
| EP98870236 | 1998-11-03 | ||
| EP99870069 | 1999-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1095278T3 true DK1095278T3 (da) | 2006-04-18 |
Family
ID=27239769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99934543T DK1095278T3 (da) | 1998-07-03 | 1999-06-29 | Differentialdiagnose af neurodegeneration |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1095278B1 (da) |
| JP (3) | JP2002519702A (da) |
| CN (1) | CN1316055A (da) |
| AT (1) | ATE312349T1 (da) |
| AU (1) | AU754062B2 (da) |
| BR (1) | BR9911291A (da) |
| CA (1) | CA2329523A1 (da) |
| DE (1) | DE69928809T2 (da) |
| DK (1) | DK1095278T3 (da) |
| ES (1) | ES2255280T3 (da) |
| HK (1) | HK1036834A1 (da) |
| WO (1) | WO2000002053A2 (da) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1379880A2 (en) * | 2001-03-15 | 2004-01-14 | Novartis AG | Screening for drugs against disorders associated with schizophrenia |
| EP1451217A4 (en) * | 2001-11-20 | 2005-10-12 | Atgen Co Ltd | NEW PEPTIDES PROVIDING ENVIRONMENTAL RESISTANCE, AND FUSION PROTEINS CONTAINING THOSE PEPTIDES |
| GB0203446D0 (en) * | 2002-02-14 | 2002-04-03 | Univ Lancaster | Detection and/or monitoring of synuclein-related diseases |
| US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
| WO2005001483A2 (en) * | 2003-06-27 | 2005-01-06 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts | Methods for diagnisis and differential diagnosis of dementia disorders |
| US7674599B2 (en) | 2003-11-08 | 2010-03-09 | Elan Pharmaceuticals, Inc. | Methods of using antibodies to detect alpha-synuclein in fluid samples |
| US20060094064A1 (en) * | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| EP2211183B1 (en) * | 2003-11-19 | 2013-03-06 | Satoris, Inc. | Method for diagnosis and monitoring of Alzheimer's disease |
| DE10361258A1 (de) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
| AT500321B1 (de) * | 2003-12-30 | 2006-02-15 | Red Bull Gmbh | Verfahren zur diagnose des down-syndroms |
| DE102004014841B4 (de) | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
| WO2006073734A2 (en) * | 2004-12-01 | 2006-07-13 | Whitehead Institute For Biomedical Research | Modulator of alpha-synuclein toxicity |
| ES2535978T3 (es) * | 2006-11-17 | 2015-05-19 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Procedimiento para el diagnóstico diferencial de demencias |
| EP2118300B1 (en) * | 2007-02-23 | 2015-05-27 | Prothena Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| EP2020602A1 (en) * | 2007-08-02 | 2009-02-04 | Araclon Biotech | High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest |
| JP2009052933A (ja) * | 2007-08-24 | 2009-03-12 | Rakuno Gakuen | プリオン病の検出方法及び診断キット |
| WO2009039586A2 (en) * | 2007-09-28 | 2009-04-02 | Powmri Limited | Biomarkers for parkinson's disease |
| WO2009086306A1 (en) | 2007-12-21 | 2009-07-09 | Whitehead Institute For Biomedical Research | Modulators of alpha-synuclein toxicity |
| JP5747414B2 (ja) * | 2008-04-29 | 2015-07-15 | バイオアークティック ニューロサイエンス アーベー | α−シヌクレイン関連疾患についての治療および診断方法における使用のための抗体およびワクチン |
| WO2009152607A1 (en) * | 2008-06-16 | 2009-12-23 | Ottawa Hospital Research Institute | Methods and kits for diagnosing neurodegenerative disease |
| ES2541213T3 (es) * | 2009-09-16 | 2015-07-16 | United Arab Emirates University | Agente de diagnóstico para la enfermedad de Parkinson |
| US9682132B2 (en) | 2010-01-26 | 2017-06-20 | Banyan Biomarkers, Inc | Compositions and methods relating to argininosucccinate synthetase |
| EP2539366B1 (en) | 2010-02-26 | 2017-11-08 | BioArtic Neuroscience AB | Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| AU2011235892B2 (en) * | 2010-04-01 | 2016-07-07 | Banyan Biomarkers, Inc. | Markers and assays for detection of neurotoxicity |
| GB201011420D0 (en) | 2010-07-06 | 2010-08-18 | United Arab Emirates Universit | Method for diagnosis |
| UA118441C2 (uk) * | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
| WO2015111430A1 (ja) | 2014-01-21 | 2015-07-30 | 株式会社 島津製作所 | Ａｐｐ切断型ペプチドの測定方法 |
| EP3540441A1 (en) | 2014-05-22 | 2019-09-18 | Shimadzu Corporation | Surrogate biomarker for evaluating intracerebral amyloid ss peptide accumulation and method for analysis thereof |
| EP3191847A1 (en) * | 2014-09-10 | 2017-07-19 | AbbVie Deutschland GmbH & Co. KG | Rgma fragment based diagnostic assay |
| EP3351939B1 (en) | 2015-09-16 | 2020-11-04 | Shimadzu Corporation | Multiplex biomarker for use in evaluation of state of accumulation of amyloid b in brain, and analysis method for said evaluation |
| EP3242134A1 (en) * | 2016-05-04 | 2017-11-08 | Euroimmun Medizinische Labordiagnostika AG | Assay for the diagnosis of a neurological disease |
| US11852635B2 (en) * | 2016-11-16 | 2023-12-26 | Nano Somix, Inc | Quantification of subpopulations of exosomes and diagnosis of neurogenerative disorders |
| US10364286B2 (en) * | 2016-12-22 | 2019-07-30 | H. Lundbeck A/S | Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation |
| GB201814807D0 (en) * | 2018-09-12 | 2018-10-24 | Univ Newcastle | Dementia Biomarkers |
| LT3660509T (lt) * | 2018-11-29 | 2022-05-10 | Hugel Inc. | Ląstelių panaudojimu paremtas būdas botulino toksino aktyvumui nustatyti |
| AU2021298222A1 (en) | 2020-06-26 | 2022-12-15 | Bioarctic Ab | α-synuclein protofibril-binding antibodies |
| JP2023551542A (ja) * | 2020-11-30 | 2023-12-08 | エニグマ バイオインテリジェンス，インコーポレイテッド | アルツハイマー病の非侵襲的評価 |
-
1999
- 1999-06-29 ES ES99934543T patent/ES2255280T3/es not_active Expired - Lifetime
- 1999-06-29 BR BR9911291-4A patent/BR9911291A/pt not_active IP Right Cessation
- 1999-06-29 AT AT99934543T patent/ATE312349T1/de active
- 1999-06-29 DE DE69928809T patent/DE69928809T2/de not_active Expired - Lifetime
- 1999-06-29 DK DK99934543T patent/DK1095278T3/da active
- 1999-06-29 CN CN99810286.5A patent/CN1316055A/zh active Pending
- 1999-06-29 WO PCT/EP1999/004483 patent/WO2000002053A2/en active IP Right Grant
- 1999-06-29 CA CA002329523A patent/CA2329523A1/en not_active Abandoned
- 1999-06-29 JP JP2000558397A patent/JP2002519702A/ja active Pending
- 1999-06-29 EP EP99934543A patent/EP1095278B1/en not_active Expired - Lifetime
- 1999-06-29 AU AU50290/99A patent/AU754062B2/en not_active Ceased
-
2001
- 2001-08-10 HK HK01105565A patent/HK1036834A1/xx not_active IP Right Cessation
-
2005
- 2005-11-10 JP JP2005326503A patent/JP2006091025A/ja active Pending
-
2009
- 2009-10-28 JP JP2009247559A patent/JP4580455B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1095278B1 (en) | 2005-12-07 |
| AU5029099A (en) | 2000-01-24 |
| CN1316055A (zh) | 2001-10-03 |
| ATE312349T1 (de) | 2005-12-15 |
| AU754062B2 (en) | 2002-10-31 |
| EP1095278A2 (en) | 2001-05-02 |
| BR9911291A (pt) | 2001-12-04 |
| JP2006091025A (ja) | 2006-04-06 |
| DE69928809T2 (de) | 2006-08-31 |
| JP4580455B2 (ja) | 2010-11-10 |
| CA2329523A1 (en) | 2000-01-13 |
| DE69928809D1 (de) | 2006-01-12 |
| HK1036834A1 (en) | 2002-01-18 |
| JP2002519702A (ja) | 2002-07-02 |
| WO2000002053A3 (en) | 2000-02-24 |
| JP2010019864A (ja) | 2010-01-28 |
| ES2255280T3 (es) | 2006-06-16 |
| WO2000002053A2 (en) | 2000-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1095278T3 (da) | Differentialdiagnose af neurodegeneration | |
| DE50304023D1 (de) | Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern | |
| CY1115366T1 (el) | Δεικτες ογκου | |
| DE60228684D1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
| ATE328278T1 (de) | Sammelapparat für einschrittigen test von mundflüssigkeiten | |
| WO2002057787A3 (en) | Detection of survivin in the biological fluids of cancer patients | |
| GB9506050D0 (en) | Assaying collagen fragments in body fluids | |
| FR2664702B1 (fr) | Procede de reduction d'interferences dans un dosage par fluorescence. | |
| DE50104561D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente | |
| ATE369564T1 (de) | Differenzielles immunoassay für myoglobin | |
| FR2879290B1 (fr) | Procede et installation de determination de caracteristiques rheologiques d'un fluide, et procede d'identification correspondant | |
| WO2002057793A3 (en) | Method of detecting prp protein and kits therefor | |
| ES2126151T3 (es) | Metodo para cuantificar bpi extracelular en fluidos corporales. | |
| WO2002059617A3 (en) | Standard diluent for multiplex assays | |
| WO2001083816A3 (en) | Method for detecting tumors | |
| ATE377192T1 (de) | Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls | |
| DK0958500T3 (da) | Immunohistokemisk påvisningsassay for carcinomproliferationsstatus | |
| BR0115689A (pt) | Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata | |
| DK1687636T3 (da) | Hurtig bestemmelse af forskellige former for hepatocytvækstfaktor (HGF) i legemsvæsker | |
| DK1297342T3 (da) | Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II | |
| DK1664330T3 (da) | Blod- og urintest | |
| PT1218749E (pt) | Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre | |
| SE0100595D0 (sv) | Immunological detection of prostate diseases and prostatic-related diseases | |
| FI943921A (fi) | Vapaan trypsinogeeni-2:n määritys | |
| ATE229183T1 (de) | Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d- spiegels in körperflüssigkeiten |